$28.66
Price
$1.7B
Market Cap
—
P/E Ratio
-4.4
Forward P/E
$-7.01
EPS (TTM)
—
Dividend Yield
$953M
Cash
$57M
Total Debt
58M
Shares Out
$22.24
$46.00
52-Week Range
Institutional Ownership of AGIOS PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for AGIOS PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for AGIOS PHARMACEUTICALS INC
6 Months Insider Sentiment
Buy $0
Sell $1.6M
0
Buys
15
Sells
-1.6M
Net
0
Grants
Largest
$338K
Goff
$315K
Jr.
$169K
Goff
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 05, 2026 | Tsveta Milanova | Chief Commercial Officer | SELL | 2.9K | $27.02 | $78K |
| Jan 05, 2026 | Tsveta Milanova | Chief Commercial Officer | EXERCISE | 8.5K | — | — |
| Dec 30, 2025 | Brian Goff | Chief Executive Officer | SELL | 6.2K | $27.09 | $169K |
| Dec 30, 2025 | Brian Goff | Chief Executive Officer | SELL | 12.5K | $27.09 | $338K |
| Dec 30, 2025 | Cecilia Jones | Chief Financial Officer | EXERCISE | 6.0K | — | — |
| Dec 30, 2025 | Cecilia Jones | Chief Financial Officer | SELL | 2.9K | $27.09 | $79K |
| Dec 30, 2025 | James William Burns | Chief Legal Officer | EXERCISE | 6.0K | — | — |
| Dec 30, 2025 | Brian Goff | Chief Executive Officer | EXERCISE | 25.5K | — | — |
| Dec 30, 2025 | Brian Goff | Chief Executive Officer | EXERCISE | 12.8K | — | — |
| Dec 30, 2025 | James William Burns | Chief Legal Officer | SELL | 2.9K | $27.09 | $79K |
| Dec 30, 2025 | Sarah Gheuens | Chief Medical Officer | EXERCISE | 6.0K | — | — |
| Dec 30, 2025 | Sarah Gheuens | Chief Medical Officer | SELL | 2.9K | $27.09 | $79K |
| Dec 30, 2025 | Tsveta Milanova | Chief Commercial Officer | EXERCISE | 6.0K | — | — |
| Dec 30, 2025 | Tsveta Milanova | Chief Commercial Officer | SELL | 2.9K | $27.09 | $79K |
| Nov 12, 2025 | David Scadden | Director | EXERCISE | 200 | $18.09 | $4K |
| Nov 12, 2025 | David Scadden | Director | SELL | 200 | $43.84 | $9K |
| Nov 11, 2025 | Sarah Gheuens | Chief Medical Officer | SELL | 2.5K | $43.78 | $107K |
| Nov 11, 2025 | Sarah Gheuens | Chief Medical Officer | EXERCISE | 2.5K | $25.01 | $61K |
| Oct 30, 2025 | Sarah Gheuens | Chief Medical Officer | EXERCISE | 200 | $25.01 | $5K |
| Oct 30, 2025 | Sarah Gheuens | Chief Medical Officer | SELL | 200 | $43.81 | $9K |
| Oct 27, 2025 | Sarah Gheuens | Chief Medical Officer | SELL | 3.3K | $43.92 | $145K |
| Oct 27, 2025 | Sarah Gheuens | Chief Medical Officer | EXERCISE | 3.3K | $25.01 | $83K |
| Oct 08, 2025 | David Scadden | Director | EXERCISE | 200 | $18.09 | $4K |
| Oct 08, 2025 | David Scadden | Director | SELL | 200 | $41.00 | $8K |
| Sep 30, 2025 | David Scadden | Director | SELL | 200 | $40.00 | $8K |
| Sep 30, 2025 | David Scadden | Director | EXERCISE | 200 | $18.09 | $4K |
| Sep 26, 2025 | Cecilia Jones | Chief Financial Officer | SELL | 3.7K | $36.77 | $134K |
| Sep 26, 2025 | Cecilia Jones | Chief Financial Officer | EXERCISE | 7.5K | — | — |
| Sep 05, 2025 | Theodore James Washburn Jr. | Principal Accounting Officer | SELL | 8.5K | $36.87 | $315K |